Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This Phase II randomized study is to determine the efficacy and toxicity of Nimotuzumab in combined with chemoradiotherapy for unresectable,local advanced squamous cell lung cancer.
Critère d'inclusion
- non-small cell lung cancer